SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Van der Heijde DM, van 't Hof M, van Riel PL, van Leeuwen MA, van Rijswijk MH, van de Putte LB. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 1992; 51: 17781.
  • 2
    Van der Heijde DM, van 't Hof M, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 91620.
  • 3
    Van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993; 20: 57981.
  • 4
    Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 448.
  • 5
    Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 72735.
  • 6
    Van Gestel AM, Anderson JJ, van Riel PL, Boers M, Haagsma CJ, Rich B, et al. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. J Rheumatol 1999; 26: 70511.
  • 7
    Van Riel PL, van Gestel AM, van de Putte LB. Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. Br J Rheumatol 1996; 35 Suppl 2: 47.
  • 8
    Wolfe F, Pincus T. Listening to the patient: a practical guide to self-report questionnaires in clinical care. Arthritis Rheum 1999; 42: 1797808.
  • 9
    Wolfe F, Pincus T. Data collection in the clinic. Rheum Dis Clin North Am 1995; 21: 32158.
  • 10
    Wolfe F, Hawley DJ, Cathey MA. Health status measures over time: serial assessments in 442 RA patients [abstract]. Arthritis Rheum 1989; 32 Suppl 4: S64.
  • 11
    Van Riel PL, Schumacher HR Jr. How does one assess early rheumatoid arthritis in daily clinical practice? Best Pract Res Clin Rheumatol 2001; 15: 6776.
  • 12
    British Society of Rheumatology. Guidelines for prescribing TNF-α blockers in adults with rheumatoid arthritis. London: British Society of Rheumatology; 2001.
  • 13
    Hjardem E, Hetland ML, Ostergaard M, Krogh NS, Kvien TK. Prescription practice of biological drugs in rheumatoid arthritis during the first 3 years of postmarketing use in Denmark and Norway: criteria are becoming less stringent. Ann Rheum Dis 2005; 64: 12203.
  • 14
    Den Broeder AA, Creemers MC, van Gestel AM, van Riel PL. Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-α. Rheumatology (Oxford) 2002; 41: 63842.
  • 15
    Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 16
    Fuchs H, Pincus T. Limitations in the usefulness of the 28-joint count: comment on the article by Fuchs and Pincus and the editorial by the American College of Rheumatology [reply]. Arthritis Rheum 1994; 37: 17123.
  • 17
    Wolfe F, Michaud K, Pincus T. Development and validation of the Health Assessment Questionnaire II: a revised version of the Health Assessment Questionnaire. Arthritis Rheum 2004; 50: 3296305.
  • 18
    Pincus T, Swearingen C, Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly Health Assessment Questionnaire format. Arthritis Rheum 1999; 42: 222030.
  • 19
    Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983; 26: 134653.
  • 20
    Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol 1996; 23: 140717.
  • 21
    Stucki G, Liang MH, Stucki S, Bruhlmann P, Michel BA. A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research: psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995; 38: 7958.
  • 22
    Wolfe F. Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease. J Rheumatol 2003; 30: 36978.
  • 23
    Ware JE, Kosinski M. The SF-36 physical and mental health summary scales: a manual for users of version 1, second edition. 1st ed. Lincoln (RI): QualityMetric; 2001.
  • 24
    Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 47383.
  • 25
    Newson R. Parameters beyond “nonparametric” statistics: Kendall's tau, Somer's D and median differences. Stata J 2002; 2: 4564.
  • 26
    Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 13560.
  • 27
    Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 25568.